Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL
Open Access
- 1 July 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (28), 26605-26613
- https://doi.org/10.1074/jbc.m100740200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.JCI Insight, 1998
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosisCurrent Biology, 1996
- Linomide prevents the lethal effect of anti-Fas antibody and reduces Fas-mediated ceramide production in mouse hepatocytes.JCI Insight, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Reduced Growth Capacity of Hepatocytes from c-myc and c-myc/TGF-α Transgenic Mice in Primary CultureBiochemical and Biophysical Research Communications, 1996
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- CCl4−induced toxicity in isolated hepatocytes: The importance of direct solvent injuryHepatology, 1986